Congenital anomalies after first-trimester dydrogesterone therapy during in vitro fertilization
Open Access
- 5 December 2025
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 24 (1)
Abstract
Background: Congenital anomalies are a critical public health concern and warrant prioritization in research. However, the teratogenic potential of dydrogesterone (DYG) remains uncertain and a subject of ongoing debate. Methods: This retrospective cohort study included patients undergoing embryo transfer between January 2010 and December 2018. It analyzed 124,815 embryo transfer cycles (80,103 [64.2%] fresh; 44,712 [35.8%] frozen), resulting in 52,175 live births. Newborns were stratified by maternal luteal phase support (DYG-exposed vs. unexposed). Patients with known congenital malformation risk factors were excluded. Congenital anomaly incidence was compared between groups. Stratified analysis and multivariate logistic regression models adjusting for confounders were employed. Results: The total congenital anomaly rate was significantly lower in DYG-exposed newborns compared to unexposed groups (6.05‰ vs. 7.90‰, P = 0.020), with particularly notable differences in musculoskeletal malformations (0.63‰ vs. 1.33‰, P = 0.025). No significant differences were observed in other congenital anomaly categories. After stratifying by fresh or frozen cycles, DYG-exposed and unexposed groups showed no significant differences in birth defects during fresh cycles. In frozen cycles, musculoskeletal anomalies were significantly lower in the DYG group both before (0.60‰ vs. 2.37‰, P = 0.020) and after adjustment ( P = 0.009, OR: 0.19, 95% CI: 0.05–0.66). Other anomaly categories remained unaffected. However, this specific association did not remain significant after rigorous correction for multiple testing with the application of both the Bonferroni and False Discovery Rate (FDR) methods. Multivariate analysis adjusted for confounders revealed no increased risk of congenital anomalies associated with DYG exposure. Conclusions: First-trimester dydrogesterone therapy was not associated with an increased risk of congenital anomalies. Due to the limitations of this cohort study, further follow-up and in-depth data analysis are planned for future studies.Keywords
Funding Information
- National Natural Science Foundation of China (82001630)
- National Key Research and Development Program of China (2023YFC2705504)
- Key Clinical Projects of Peking University Third Hospital (BYSYZD2024004)
This publication has 40 references indexed in Scilit:
- Association of birth defects with the mode of assisted reproductive technology in a Chinese data-linkage cohortFertility and Sterility, 2018
- Oral dydrogesterone for luteal phase support in fresh in vitro fertilization cycles: a new standard?Fertility and Sterility, 2018
- Assisted Reproductive Technology and Birth Defects Among Liveborn Infants in Florida, Massachusetts, and Michigan, 2000-2010JAMA Pediatrics, 2016
- Reflections on the etiology of structural birth defects: Established teratogens and risk factorsBirth Defects Research Part A: Clinical and Molecular Teratology, 2015
- The Impact of Oral Intake of Dydrogesterone on Fetal Heart Development During Early PregnancyPediatric Cardiology, 2015
- Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trialEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysisFertility and Sterility, 2012
- A meta-analysis of the impact of IVF and ICSI on major malformations after adjusting for the effect of subfertilityJournal of Assisted Reproduction and Genetics, 2011
- Dydrogesterone use during pregnancy: Overview of birth defects reported since 1977Early Human Development, 2009
- Nongenital malformations following exposure to progestational drugs: The last chapter of an erroneous allegationBirth Defects Research Part A: Clinical and Molecular Teratology, 2005